Company Filing History:
Years Active: 2020-2025
Title: Innovations in Cancer Treatment by Inventor Sang Hyun Min
Introduction
Sang Hyun Min is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at preventing and treating cancer. With a total of 2 patents, his work showcases innovative approaches to combat this challenging disease.
Latest Patents
Sang Hyun Min's latest patents include a pharmaceutical composition comprising trimebutine or its pharmaceutically acceptable salt as an active ingredient for the prevention or treatment of cancer. This invention demonstrates an excellent effect in selectively inhibiting the growth and proliferation of cancer stem cells. The composition can suppress the recurrence, metastasis, and progression of cancer, making it a valuable option for treatment, either alone or in combination with other agents.
Another significant patent involves an imidazopyridine derivative, along with a method for preparing it and a pharmaceutical composition containing it as an active ingredient for preventing or treating cancer. This novel derivative effectively inhibits cancer-related kinases and shows promise in inhibiting the proliferation of cancer cells in various models. Additionally, it has been confirmed to be useful in treating diabetic nephropathy in animal model experiments.
Career Highlights
Sang Hyun Min has worked with reputable organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and Pimedbio, Inc. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Hwan Geun Choi and Jung Beom Son. Their collaborative efforts have likely played a role in the success of his research and patent developments.
Conclusion
Sang Hyun Min's contributions to cancer treatment through his innovative patents highlight the importance of research in pharmaceuticals. His work not only addresses critical health challenges but also paves the way for future advancements in medical science.